Viewing nowDonepezil 23 mg Tablets (Donepezil Hydrochloride Monohydrate)
Donepezil Hydrochloride Hydrate 24mg
Tablet · Prescription medication
Korea Pavis Pharmaceutical Co., Ltd.

MFDS item code 202103511 · Approved 2021.04.29
Treatment of symptoms of moderate to severe Alzheimer-type dementia
This medication is used to treat symptoms of moderate to severe Alzheimer's disease.
Take this medicine once daily in the evening, immediately before bedtime, regardless of food. If sleep disturbances such as unusual dreams, nightmares, or insomnia occur, consider taking this medicine in the morning. Because the rate of absorption may increase, do not split, crush, or chew this medicine. The recommended initial dose of donepezil hydrochloride is 5mg once daily. Since this medicine reaches steady state 15 days after starting treatment and the incidence of adverse reactions may be affected by the rate of dose escalation, administer 5mg for 4 ~ 6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10mg. When increasing the dose to 10mg daily, monitor for gastrointestinal adverse reactions. Patients who have taken 10mg once daily for at least 3 months may be given 23mg once daily.
This medication contains Donepezil Hydrochloride Monohydrate as its active ingredient and is primarily used for the treatment of Alzheimer's disease symptoms. This medication should not be administered to certain patients. For example, people allergic to this medication or its components, pregnant women, or women who may become pregnant, and patients with genetic issues such as lactose intolerance should not take this medication. Patients with heart disease or heart conduction disorders should use this medication cautiously, as it may stimulate the vagus nerve and cause heart issues such as bradycardia or arrhythmias. Patients taking non-steroidal anti-inflammatory drugs or with a history of peptic ulcers should also be careful, as this medication can increase gastric acid secretion and promote gastrointestinal motility, potentially worsening ulcer symptoms. Patients with a history of asthma or obstructive pulmonary disease may experience worsening symptoms when using this medication, so caution is advised. Patients with extrapyramidal disorders such as Parkinson's disease may have worsening symptoms due to this medication. This medication contains Yellow No. 4, so those allergic to this component should be cautious. A variety of adverse reactions may occur while taking this medication. For example, cardiovascular issues (bradycardia, heart block, myocardial infarction), gastrointestinal problems (gastric ulcer, gastrointestinal bleeding), liver function abnormalities, neurological symptoms (seizures, cerebral hemorrhage), and movement disorders have been reported. Additionally, common symptoms may include hallucinations, insomnia, dizziness, nausea, vomiting, diarrhea, loss of appetite, fatigue, headaches, and others. The frequency and intensity of adverse reactions may vary depending on the dosage of this medication, particularly at higher doses, where gastrointestinal symptoms such as nausea, vomiting, and diarrhea may occur more frequently. During treatment, the patient's condition should be regularly monitored, and immediate consultation with medical personnel should occur if any unusual symptoms appear. Pregnant or nursing women are advised not to use this medication and should make careful decisions after consulting with a physician if it is absolutely necessary. Safety for pediatric use has not yet been established, so children should not take this medication. This medication may interact with other drugs, so if there are any concomitant medications, it is essential to inform the doctor or pharmacist. Caution is especially necessary when used with medications affecting the heart, those affecting liver metabolism, and neuromuscular blocking agents. In case of overdose, severe symptoms such as nausea, vomiting, severe muscle weakness, and respiratory distress may occur, so immediate medical attention is required. This medication should be stored out of reach of children, and it is important to keep it in the original container without transferring it to another to maintain safety and quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that is well-ventilated. The recommended storage temperature is between 1°C and 30°C, maintaining room temperature. This helps maintain the effectiveness of the medication.
Red, round, film-coated tablets that are convex on both sides
30 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDonepezil Hydrochloride Hydrate 24mg
Tablet · Prescription medication
Korea Pavis Pharmaceutical Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.